Skip to content

Laser Cell Therapy for Knee Cartilage Repair

Combined Effect of IPG Medical Charlie Laser and Bone Marrow Grafting on Cartilage Defects of the Knee

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04001361
Enrollment
45
Registered
2019-06-28
Start date
2019-07-15
Completion date
2020-12-31
Last updated
2019-06-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis

Brief summary

Laser pulsed energy will be delivered over an optical fiber to create channels into damaged cartilage of the knee or knees. The channels have a diameter of approximately 100 microns or less and an approximate depth of 1 millimeter or less. Bone marrow aspirate will then be delivered into the damaged joint.

Detailed description

The creation of micro-channels into damaged knee cartilage will facilitate the movement of fluid into and out of the tissue to allow for more efficient nutrient diffusion. The addition of bone marrow aspirate will provide additional growth factor enriched nutrition to the tissue. The goal of this combination therapy is to facilitates the body's own reparative processes leading to improved patient well being.

Interventions

PROCEDURELaser Cell Therapy

Bone marrow aspirate combined with laser to alter the cartilage matrix to facilitate repair

Sponsors

Endocellutions
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Masking description

Sham laser means laser not turned on. Sham marrow means incision in skin made but no marrow drawn. Patient under conscience sedation. MRI and outcomes measures independently measured.

Intervention model description

Blinded trial. Three groups. Sham, laser only, laser plus marrow. Stage 2 and 3 OA of one or both knees

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Kellergren grading scale of 2 or 3 in at least one compartment of either or both knees with no compartment representing a stage 4 in either knee. No significant MCL or LCL tear or laxity No significant meniscal tear. ( i.e. bucket handle)

Exclusion criteria

* Injection with the past 6 weeks * Stage 4 osteoarthritis in either knee * Uncontrolled Diabetes or any other metabolic syndrome * BMI greater than 28 * Significant lower extremity deformity * Bilateral or tri compartmental Knee OA * Adults unable to consent * Individuals who are not yet adults (infants, children, and teenagers, age \< 18) * pregnant women * Prisoners * Stage 4 osteoarthritis in either knee * Subjects, who, in the opinion of the investigator, for any reason other than those listed above, will not be able to complete the study per protocol.

Design outcomes

Primary

MeasureTime frameDescription
MRIone yearPre procedure MRI and post MRI is taken to measure disease modification
VAS Scoreone yearPre procedure and post procedure Pain score
KOOS scoreone yearPre procedure and post procedure Improvement in daily living and pain
Treadmill Testone yearPre procedure and post procedure, the patient will walk for 12 minutes with a gradual increase and a change in pain will be evaluated
Swiss Ball wall squat testone yearSwiss Ball wall squat test to asses functional recovery.

Countries

United States

Contacts

Primary ContactGennie Arbogast, DO
garbogast@trinityhealth.org7402648000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026